22.09.2017
- US drugmaker Catalent has agreed to buy contract development and manufacturing organization (CDMO) Cook Pharmica for $950 million in cash, boosting its position in the fast-growing...
28.10.2016
- Catalent Pharma Solutions has broken ground on a $34 million extension to its biologics manufacturing facility in Madison, Wisconsin, USA. When completed, the additional 22,000...
30.09.2016
- Catalent has announced plans to acquire Pharmatek Laboratories, a contract drug development and clinical manufacturing company, for an all-cash undisclosed sum. The acquisition...
Growth in the global oncology drug market is an important measure of opportunities in drug development and manufacturing, including for contract manufacturers of active...
18.04.2016
- Lonza, a leading worldwide supplier of biopharmaceuticals to the pharmaceutical and biotechnology industries headquartered in Basel, Switzerland, has offered to acquire Catalent...
08.02.2016
- Catalent Pharma Solutions has said it will invest $4.6 million in a further expansion of its Singapore clinical supply facility to support global and regional customers’ growth in...
14.01.2016
- Redwood Bioscience, a subsidiary of Catalent, a US-based global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health...
11.12.2015
- Catalent Pharma Solutions has signed an exclusive long term supply agreement with Pfizer to produce over-the-counter heartburn treatment, Nexium 24HR (esomeprazole), branded as...
